Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Mar 29;336(7646):679-80.
doi: 10.1136/bmj.39505.490544.BE. Epub 2008 Mar 5.

African sleeping sickness

Francesco Checchi, Michael P Barrett
Editorial

African sleeping sickness

Francesco Checchi et al. BMJ. .

Abstract

Eflornithine should be the drug of choice for stage 2 disease, but resistance must be monitored

PubMed Disclaimer

Conflict of interest statement

Competing interests: FC was previously employed by MSF and Epicentre, the sponsors of the study that is the subject of this editorial; he also collaborates with some of the study’s authors on several research projects on African sleeping sickness, based on data from MSF programmes.

Comment on

References

    1. Priotto G, Pinoges L, Fursa IB, Burke B, Nicolay N, Grillet G, et al. Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. BMJ 2008. doi: 10.1136/bmj.39485.592674.BE - DOI - PMC - PubMed
    1. Stich A, Abel PM, Krishna S. Human African trypanosomiasis. BMJ 2002;325:203-6. - PMC - PubMed
    1. Barrett MP, Boykin DW, Brun R, Tidwell RR. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol 2007;152:1155-71. - PMC - PubMed
    1. Burri C, Brun R. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 2003;90(supp 1):S49-52. - PubMed
    1. Louis FJ, Keiser J, Simarro PP, Schmid C, Jannin J. (Eflornithine in the treatment of African trypanosomiasis). Med Trop (Mars) 2003;63:559-63. - PubMed

MeSH terms